Altesa BioSciences unveils breakthrough data on Rhinovirus Drug at ICAR2026
Vapendavir is an oral, potent, broad-spectrum antiviral active against rhinoviruses and related respiratory enteroviruses
Vapendavir is an oral, potent, broad-spectrum antiviral active against rhinoviruses and related respiratory enteroviruses
Both companies say the collaboration is driven by a shared mission to improve patient outcomes by aligning every step of the diagnostic process
The facility features 2,176 high-performance GPUs across the US and Europe
The expanded program allows patients to fill prescriptions either at a local pharmacy or through home delivery via LillyDirect
Cadila Pharmaceuticals’ journey has been marked by several milestones, including the development of indigenous formulations, expansion into global markets, and the creation of robust manufacturing and R&D capabilities
Previously, Arexvy was authorized for adults 60 and older, and for those 50–59 with heightened risk
The expansion builds on Veristat’s work helping Chinese pharmaceutical firms such as Hansoh Pharma and CStone Pharmaceuticals
The move comes as China rapidly expands its capabilities in the pharmaceutical sector, particularly in licensing and drug development
The endorsement follows overwhelming support for the share swap preceding the merger,
Subscribe To Our Newsletter & Stay Updated